Search

Your search keyword '"Dondorp, Arjen M"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Dondorp, Arjen M" Remove constraint Author: "Dondorp, Arjen M" Publisher oxford university press Remove constraint Publisher: oxford university press
64 results on '"Dondorp, Arjen M"'

Search Results

2. Randomized Controlled Trial of Levamisole Hydrochloride as Adjunctive Therapy in Severe Falciparum Malaria with High Parasitemia

3. Reply to Cunnington et al

4. Reduced red blood cell deformability in vivax malaria.

5. Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

6. The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study.

7. An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.

8. WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria.

9. The Effect of Regularly Dosed Acetaminophen vs No Acetaminophen on Renal Function in Plasmodium knowlesi Malaria (PACKNOW): A Randomized, Controlled Trial.

10. Evidence of Brain Alterations in Noncerebral Falciparum Malaria.

11. Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.

12. Brain Magnetic Resonance Imaging Reveals Different Courses of Disease in Pediatric and Adult Cerebral Malaria.

13. Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing Severity in Kilifi, Kenya.

14. Reduced Cardiac Index Reserve and Hypovolemia in Severe Falciparum Malaria.

15. Associations Between Restrictive Fluid Management and Renal Function and Tissue Perfusion in Adults With Severe Falciparum Malaria: A Prospective Observational Study.

16. Cell-Free Hemoglobin Is Associated With Increased Vascular Resistance and Reduced Peripheral Perfusion in Severe Malaria.

17. Antiphosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associated With Early Anemia in Both Species.

18. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.

19. Identifying the Components of Acidosis in Patients With Severe Plasmodium falciparum Malaria Using Metabolomics.

20. Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar.

21. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

22. Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi.

23. Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.

24. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.

25. Infectivity of Chronic Malaria Infections and Its Consequences for Control and Elimination.

26. The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study.

27. Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings.

28. Development of drugs for severe malaria in children.

29. Retinal Changes in Uncomplicated and Severe Plasmodium knowlesi Malaria.

30. Sequestration and Red Cell Deformability as Determinants of Hyperlactatemia in Falciparum Malaria.

31. Plasma concentration of parasite DNA as a measure of disease severity in falciparum malaria.

32. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.

34. Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia.

35. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.

36. Lethal malaria: Marchiafava and Bignami were right.

37. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.

39. Reply to Cunnington et al.

40. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration.

41. Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique.

42. Seroepidemiological surveillance of Burkholderia pseudomallei in Bangladesh.

43. Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria.

45. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.

46. Sequestration and microvascular congestion are associated with coma in human cerebral malaria.

47. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial.

48. Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children.

49. Circulating red cell-derived microparticles in human malaria.

50. The role of mathematical modelling in guiding the science and economics of malaria elimination.

Catalog

Books, media, physical & digital resources